ARPA-H Selects Atman Health to Build Voice-First AI for Heart Failure

Atman Health received a $7.7M contract from ARPA-H to develop an autonomous AI clinical agent for heart failure care, aiming to improve access and reduce costs in cardiovascular treatment. The ADVOCATE program targets creating FDA-authorized AI agents to support clinical teams and address cardiologist shortages.